Alliance Global Group, Invivoscribe Ink Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb) – The Alliance Global Group today announced an exclusive master agreement for the distribution of Invivoscribe Technologies' molecular diagnostics in Alliance's markets.

Based in San Diego, Invivoscribe's products include assays for detecting clonal gene rearrangements, gene translocations, and gene mutations in patients with suspected lymphoproliferations, among other things. It also has CLIA- and CAP-certified clinical reference laboratories in the European Union and the US to perform FLT2 and NPM1 mutation testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.